American Well Corporation (NYSE:AMWL) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 2:35 PM EDT
Company Participants
Ido Schoenberg – Chairman & CEO
Mark Hirschhorn – Executive VP, COO & CFO
Conference Call Participants
Craig Hettenbach – Morgan Stanley, Research Division
Presentation
Craig Hettenbach
VP & Equity Analyst
Good afternoon, everyone. I’m Craig Hettenbach. I cover the health tech provider space for Morgan Stanley. Very pleased to have Amwell with us so CEO and CFO here. Just before we get started, some important disclosures, you can find them at the Morgan Stanley website, www.morganstanley.com/researchdisclosures.
Question-and-Answer Session
Craig Hettenbach
Morgan Stanley, Research Division
So Ido, I thought I’d kick it off with you. And if I think just how the company has evolved the last few years kind of growth through COVID coming out of it and how the business model is evolving, I thought it would be a good chance to kind of just a refresher in terms of the business, what are some of the core value and driver propositions for Amwell services that you provide?
Ido Schoenberg
Chairman & CEO
Absolutely Craig. So in essence, our mission has not changed much. We are in the basis of enabling access to quality care that is technology driven. In other words, technology care enablement. Our core focus is something we continue to invest in, which is this experience of more and more people that are going online. We try to get them a reproducible experience that is phenomenal to help understand what their issue is and match them with the right clinical program.
We have our own clinical programs in long list of areas, including urgent care, virtual primary care, behavioral health, like patient nutrition and many other things. And growing list of partners, third parties with other clinical programs. Essentially, by having one experience, we are
Credit: Source link
